Cleerly logo

Cleerly Funding & Investors

New York, NY

Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. We are developing a new standard for coronary artery disease by integrating the highest quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, we aim to provide a comprehensive solution for cardiovascular disease evaluation that offers the greatest value to the healthcare system and improves heart health for patients at risk of heart attacks.

cleerlyhealth.com

Total Amount Raised: $386,484,992

Cleerly Funding Rounds

  • Series C

    $106,000,000

    Series C Investors

    Insight Venture Partners
    Battery Ventures
  • Series C

    $223,000,000

    Series C Investors

    Fidelity
    T. Rowe Price
    Piper Heartland Healthcare Capital
    Breyer Capital
    Sands Capital Management
    New Leaf Ventures
    Mirae Asset Capital
    Novartis
    Peter Thiel
    DigiTx Partners
    Vensana Capital
    Cigna Ventures
    LRVHealth
    Presight Capital
    THE CATALYTIC IMPACT FOUNDATION (CIF)
  • Series B

    $43,000,000

    Series B Investors

    Vensana Capital
    New Leaf Venture Partners
    American College of Cardiology
    DigiTx Partners
    Cigna Ventures
    LRVHealth
    Jay Zaveri
  • Series A

    $14,484,975

Funding info provided by Diffbot.